Calmer Co International Limited · ASX:CCO
Calmer Co International — The Calmer Co International — Investor Presentation (July 2023)
25 slides from Calmer Co International's investor presentation, Jul 20, 2023
Slide 1: For personal use only
For personal use only ASX:CCO
Slide 2: Vision, purpose, mission
For personal use only vision purpose mission
Slide 3: Stress growing among young consumers
stress growing among young consumers 74% 67% For personal use only 3x’s
Slide 4: Anxiety is very common and largely untreated
anxiety is very common and largely untreated 61% For personal use only 18% 36%
Slide 5: Anxiety, sleep and stress
37% For personal use only 43% anxiety sleep stress 21%
Slide 6: Kavalactones have unique pharmacology addressing stress, sleeplessness and anxiety
KAVALACTONES HAVE UNIQUE PHARMACOLOGY WHICH. ADDRESSES STRESS, SLEEPLESSNESS AND AETY Er cei <i a city Sal saa So 2 el Oe Cure hs ec Bia | RS oy RA! 4 es i % ¥ x ee eS Tein \
Slide 7: Clinical evidence
For personal use only clinical evidence 6
Slide 8: Use case in traditional Chinese medicine
use case in traditional chinese medicine For personal use only 6
Slide 9: Our brands: Fijikava
For personal use only our brands: fijikava
Slide 10: Our brands: Taki Mai
For personal use only our brands: taki mai
Slide 11: Our brands: Danodan
For personal use only our brands: danodan
Slide 12: Supply chain excellence: real results in Q4
CALMER # SUPPLY CHAIN EXCELLENCE FOCUS ON HIGHER MARGINS AND" GROWTH ALONGSIDE-COST i SAVINGS ARE NOW SHOWING] eer DISTRIBUTION PARTNERSHIPS REAL RESULTS IN Q4 * SALES UP 80% in Q4 INNOVATION & PRODUCT *- GROSS MARGIN +19% vs FY22 DEVELOPMENT - OPEX DOWN 1.5m vs FY22 - EBITA +25% vs FY22 ‘ ( LEAN CO
Slide 13: Supply chain goes from strength to strength
Supply chain goes from strength to strength For personal use only • • • • • •
Slide 14: Group and segment updates
For personal use only Group and segment updates
Slide 15: Group Highlights
Group Highlights For personal use only • • • • • • •
Slide 16: Group Performance
Group Performance For personal use only • Revenue growth accelerating since January • Expenses as % of sales on steady downward trend • Net loss reducing • Net margin improving • US business now profitable on monthly basis • Fiji business largely self-sustaining • Australia business now on a positiv
Slide 17: USA Performance
USA Performance For personal use only • Overheads as % of Sales in Q4 tracking 1/6th of Q2 • Shipping and Logistics to USA beginning to normalise • Full effect of cost reductions to be felt in Q1/24 • #1 Instant Kava Brand!!! • Daily sales now averaging AUD2.4k and growing • Kava market on Amazon es
Slide 18: Australia Performance
Australia Performance For personal use only
Slide 19: Fiji performance
For personal use only Fiji performance
Slide 20: Growth Pillars FY24
For personal use only Growth Pillars FY24
Slide 21: e-Commerce focus: scalable low-cost access to USA
e-COMMERCE FOCUS Scalable Low-Cost Access to USA For personal use only
Slide 22: USA Kava Bar Market
USA KAVA BAR MARKET Rapidly Growing Direct & B2B Sales For personal use only • • • • • • • • •
Slide 23: China and Beyond
For personal use only • • • China and Beyond
Slide 24: Profitable retail: Coles Australia and CJ Patel
PROFITABLE RETAIL Coles Australia and CJ PATEL <j Patel - Taki Mai® 17 Countries Sales targets over three years are set at A$11m (FJD17m) to retain exclusivity over an initial three-year term; -FJD 3m in year 1, - FJD 6m in year 2, and - FJD 8m in year 3. * Fijiand 12 Pacific Islands Launched in May
Slide 25: Vinaka (thank you)
For personal use only vinaka (thank you)
The Calmer Co International — Investor Presentation (July 2023) on 6ix